# Hippophae rhamnoides L. Fruit Extract Relieves Chronic Idiopathic Constipation and Improves Bowel Function: A Monocentric, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial

**Authors:** Maria Vittoria Morone, Gaia Spadarella, Alessandro Di Minno, Marcello Cordara, Angela Cerqua, Lorenza Francesca De Lellis, Daniele Giuseppe Buccato, Alessandra Baldi, Roberto Piccinocchi, Hammad Ullah, Gaetano Piccinocchi, Xiang Xiao, Roberto Sacchi, Maria Daglia

PMC · DOI: 10.3390/nu18050806 · Nutrients · 2026-02-28

## TL;DR

A clinical trial found that sea buckthorn fruit extract improved bowel function and reduced symptoms in people with chronic constipation.

## Contribution

This is the first clinical trial to demonstrate the efficacy of Hippophae rhamnoides extract in treating chronic idiopathic constipation.

## Key findings

- H. rhamnoides extract significantly increased weekly spontaneous bowel movements.
- Stool consistency improved significantly in the treatment group.
- No adverse events were reported with the extract.

## Abstract

Background/Objectives: Chronic idiopathic constipation (CIC) is a common gastrointestinal disorder with a global prevalence of about 14%, common in women and elderly population. It often lacks effective treatment. This randomized clinical trial was aimed to evaluate the efficacy and tolerability of Hippophae rhamnoides L. (sea buckthorn) fruit extract in adults with CIC. Methods: A UHPLC-HRMS/MS analysis was performed on the hydroethanolic H. rhamnoides fruit extract to evaluate its composition. Ninety participants were randomly assigned to receive either 500 mg of H. rhamnoides extract or placebo delivered through a capsule daily for 28 days. The primary outcome was the change in weekly spontaneous complete bowel movements (SCBMs), while secondary outcomes included stool consistency (Bristol Stool Form Scale—BSFS), gastrointestinal symptoms, and quality of life (SF-12). Results: Metabolic profile of the extract tentatively identified 75 bioactive compounds, predominantly flavonoids, triterpenoids and phospholipids. H. rhamnoides fruit extract significantly improved SCBM frequency (from 1.5 to 2.6 per week; p < 0.001) and normalized stool consistency (mean BSFS score from 1.4 to 3.5; p < 0.001), compared to no change in the placebo group. Significant reductions in bloating, abdominal pain, and heaviness were observed, while flatulence showed no between-group significant difference. No adverse events or use of rescue treatments were reported. Quality-of-life scores remained largely unchanged, with a non-significant trend towards improved mental health in the treated group. Conclusions: These findings suggest that H. rhamnoides fruit extract is a safe and effective option for managing CIC, offering an alternative to other plant extracts with laxative effects.

## Full-text entities

- **Diseases:** gastrointestinal symptoms (MESH:D012817), gastrointestinal disorder (MESH:D005767), flatulence (MESH:D005414), abdominal pain (MESH:D015746), CIC (MESH:D003248)
- **Chemicals:** flavonoids (MESH:D005419), phospholipids (MESH:D010743), triterpenoids (MESH:D014315), H. rhamnoides extract (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12987243/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12987243/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12987243/full.md

---
Source: https://tomesphere.com/paper/PMC12987243